Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A

av Yu, H-C, Hung, M-H, Chen, Y-L, Chu, P-Y, Wang, C-Y, Chao, T-T, Liu, C-Y, Shiau, C-W, Chen, K-F
Publicerad 2014